Literature DB >> 28870636

De novo ERBB2 amplification causing intrinsic resistance to erlotinib in EGFR-L858R mutated TKI-naïve lung adenocarcinoma.

Brian J Carney1, Deepa Rangachari2, Paul A VanderLaan3, Kyle Gowen4, Alexa B Schrock4, Siraj M Ali4, Daniel B Costa1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28870636     DOI： 10.1016/j.lungcan.2017.08.018

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  4 in total

1.  TP53 mutations are predictive and prognostic when co-occurring with ALK rearrangements in lung cancer.

Authors:  D B Costa
Journal:  Ann Oncol       Date:  2018-10-01       Impact factor: 32.976

2.  High KRT8 Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients.

Authors:  Longxiang Xie; Yifang Dang; Jinshuai Guo; Xiaoxiao Sun; Tiantian Xie; Lu Zhang; Zhongyi Yan; Hamel Amin; Xiangqian Guo
Journal:  Genes (Basel)       Date:  2019-01-10       Impact factor: 4.096

3.  Analytical and clinical validation of a custom 15-gene next-generation sequencing panel for the evaluation of circulating tumor DNA mutations in patients with advanced non-small-cell lung cancer.

Authors:  Yock Ping Chow; Norziha Zainul Abidin; Ken Siong Kow; Lye Mun Tho; Chieh Lee Wong
Journal:  PLoS One       Date:  2022-10-18       Impact factor: 3.752

4.  Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.

Authors:  Linjie Luo; Chao Liang
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.